-
-
While most AIDS activists and scientists agree that its a good idea to target more prevention programs at people who already are HIV-positive, some question whether the new push for HIV testing and the prevention-for-positives initiative is the right strategy at a time when other prevention dollars are drying up.
-
Neuropathies among HIV patients have continued to increase in recent years, particularly in the case of antiretroviral toxic neuropathy (ATN). Investigators have focused on developing three different types of treatments for HIV-associated neuropathies.
-
Los Angeles researchers recently have discovered clinical evidence that HIV-positive people with shy and introverted personalities tend to have a faster disease progression and less optimal outcomes under antiretroviral treatment than do people with extroverted personalities.
-
The threat of bioterrorism and the continuing emergence of new infectious agents have spurred the development of syndromic surveillance systems, which may detect clusters of cases much earlier than traditional methods. What does that buy you? Time.
-
-
According to the Occupational Safety and Health Administration (OSHA), An effective [respiratory protection] program requires a systematic approach to evaluating workplace conditions, selecting the appropriate respirator, ensuring the respirator fits, and maintaining the respirator properly. Here are some provisions of the standard.
-
Hospitals are buying powered air purifying respirators (PAPRs) and trimming the ranks of employees who potentially would use respirators as a way to cut down on fit-testing.
-
TB, severe acute respiratory syndrome (SARS), smallpox, monkeypox: Your respiratory protection program needs to take into account the different transmission characteristics of each agent.
-
Confirmed cases of severe acute respiratory syndrome (SARS) in China and the emergence of a new strain of avian flu in Vietnam set the public health world on edge and highlighted one important message for hospitals: Be prepared to encounter newly emerging diseases.
